These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31630211)

  • 21. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
    Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
    Huang YH; Zhao XJ; Zhang QH; Xin XY
    Gynecol Oncol; 2009 Feb; 112(2):409-14. PubMed ID: 19038435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation.
    Albano C; Smitz J; Camus M; Riethmüller-Winzen H; Van Steirteghem A; Devroey P
    Fertil Steril; 1997 May; 67(5):917-22. PubMed ID: 9130900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge.
    Leroy I; d'Acremont M; Brailly-Tabard S; Frydman R; de Mouzon J; Bouchard P
    Fertil Steril; 1994 Sep; 62(3):461-7. PubMed ID: 8062939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis.
    Altintas D; Kokcu A; Tosun M; Cetinkaya MB; Kandemir B
    J Obstet Gynaecol Res; 2008 Dec; 34(6):1014-9. PubMed ID: 19012701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.
    Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H
    J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists.
    Danforth DR; Arbogast LK; Friedman CI
    Fertil Steril; 2005 May; 83(5):1333-8. PubMed ID: 15866565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
    Olivennes F; Belaisch-Allart J; Emperaire JC; Dechaud H; Alvarez S; Moreau L; Nicollet B; Zorn JR; Bouchard P; Frydman R
    Fertil Steril; 2000 Feb; 73(2):314-20. PubMed ID: 10685535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
    Hsieh YY; Chang CC; Tsai HD
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice.
    Lamharzi N; Halmos G; Jungwirth A; Schally AV
    Int J Oncol; 1998 Sep; 13(3):429-35. PubMed ID: 9683774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse Effects of Vincristine Chemotherapy on Cell Changes in Seminiferous Tubules and Cetrorelix GnRH Antagonist Inhibitory Effects in Mice.
    Nikpour F; Tayefi H; Mohammadnejad D; Akbarzadeh A
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):683-687. PubMed ID: 29580040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin.
    Büchter D; Behre HM; Kliesch S; Chirazi A; Nieschlag E; Assmann G; von Eckardstein A
    Exp Clin Endocrinol Diabetes; 1999; 107(8):522-9. PubMed ID: 10612483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.
    Weiss JM; König SJ; Polack S; Emons G; Schulz KD; Diedrich K; Ortmann O
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):118-26. PubMed ID: 16891115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
    Gründker C; Emons G
    Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH-releasing hormone antagonist Cetrorelix.
    Tang X; Yano T; Osuga Y; Matsumi H; Yano N; Xu J; Wada O; Koga K; Kugu K; Tsutsumi O; Schally AV; Taketani Y
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3721-7. PubMed ID: 12161501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.
    Tur-Kaspa I; Ezcurra D
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1323-36. PubMed ID: 19761413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gi protein-mediated translocation of serine/threonine phosphatase to the plasma membrane and apoptosis of ovarian cancer cell in response to gonadotropin-releasing hormone antagonist cetrorelix.
    Imai A; Sugiyama M; Furui T; Tamaya T
    J Obstet Gynaecol; 2006 Jan; 26(1):37-41. PubMed ID: 16390708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of gonadotropin-releasing hormone antagonist in ovarian stimulation.
    Olivennes F
    Clin Obstet Gynecol; 2006 Mar; 49(1):12-22. PubMed ID: 16456339
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical suppression of precocious puberty with cetrorelix after failed treatment with GnRH agonist in a girl with gonadotrophin-independent precocious puberty.
    Wu MH; Lin SJ; Wu LH; Cheng YC; Chou YY; Pan HA
    Reprod Biomed Online; 2005 Jul; 11(1):18-21. PubMed ID: 16102281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superstimulation of ovarian follicular growth with FSH oocyte recovery, and embryo production from Zebu (Bos indicus) calves: effects of treatment with a GnRH agonist or antagonist.
    Maclellan LJ; Whyte TR; Murray A; Fitzpatrick LA; Earl CR; Aspden WJ; Kinder JE; Grotjan HE; Walsh J; Trigg TE; D'Occhio MJ
    Theriogenology; 1998 May; 49(7):1317-29. PubMed ID: 10732069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.